Developmental Research Projects

Developmental Research Projects include:

• 2006-2008: "Melanoma-Induced Dermal Vascular Hyperpermeability in Humans", Martin Kluger, PhD, Research Scientist (Dermatology)
• 2006-2008: "Modulating Erythropoietin Receptor Activity in Melanoma by Small Transmembrane Proteins" Daniel DiMaio, PhD, Professor (Genetics)
• 2006-2008: “Immune tolerance mediated by photopheresis in CTCL patients treated for GVHD”, Carole Berger, PhD, Research Scientist (Dermatology) and Francine Foss, MD Professor (Oncology/Yale Cancer Center)
• 2006-2008: “Towards a Clinically Relevant Immunotherapy for Any Solid Tumor: Biodegradable Nanoparticles as Antigen Delivery Vehicles in Human Melanoma”, Douglas Hanlon, PhD, Research Scientist (Dermatology); Mark Saltzman, PhD (Biomedical Engineering)
• 2007-2008: “Sex Steroid Hormones in Melanoma” David Rimm and Bonnie Gould Rothberg, (Pathology).
• 2007-2009: “Targeting phospho-inositol-3 kinase (PI3K) in melanoma” Harriet Kluger, M.D., (Oncology/Yale Cancer Center).
• 2007-2008: "Using Synthetic Messenger RNA for Adaptive Cell Therapy of Melanoma" Peter Rabinovich, M.D., Associate Professor (Medicine)
• 2007-2008: "Parvoviral Virotherapy for Melanoma" Peter Tattersall, Ph.D., Professor (Laboratory Medicine)
• 2008-2009: "High Throughput Re-sequencing of Sequence-Selected Melanoma Exons" David Stern, PhD, Professor (Pathology) and Michael Snyder, PhD, Professor (Molecular, Cell & Developmental Biology)
• 2008-2009: “Modulating KIT Activities in Melanoma by Small Transmembrane Proteins” Daniel DiMaio, PhD, Professor (Genetics)
• 2008-2009: “Regulation of the Anti-tumor Immune Response in Melanoma Patients using CD69 as a Target” Enric Esplugues, Ph.D. Associate Research Scientist (Immunobiology)
• 2008-2009: “Characterization of TAP- and Tapasin-Independent MHC Class I-Restricted Melanoma Epitopes” Peter Cresswell, Ph.D. Professor (Immunobiology)